DN-1406131 | Interleukin Related interleukin-related.com

Product Name :
DN-1406131

Search keywords :
Tryptophanase

drugId :
null

Target Vo:
Tryptophan 2,3-dioxygenase

Target Vo Short Name :
TDO2

Moa_Name:
Indoleamine 2,3-dioxygenase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai De Novo Pharmatech Co Ltd

Active Company_Name :
Jiangxi Qingfeng Pharmaceutical Industry Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Solid tumours

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Riliprubart In Vivo
SUMO1 Rabbit mAb Autophagy
Sulfadimidine Antibody (YA906): Sulfadimidine Antibody (YA906) is an unconjugated, rabbit-derived, anti-Sulfadimidine (YA906) monoclonal antibody. Sulfadimidine Antibody (YA906) can be used for: ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts